Recent

% | $
Quotes you view appear here for quick access.

Endocyte, Inc. Message Board

  • jayn10 jayn10 Jun 18, 2014 10:46 AM Flag

    SMDC platform

    I have a modest position in ECYT....that said, IMHO I believe that Merck will one day (soon) look back and say that discontinuing our relationship with Endocyte was the biggest mistake our company ever made. Having the worldwide rights is a great coup for ECYT. Anyone with a inkling of cancer cell biology will understand the true power of Small Molecule Drug Conjugates especially in NSCLC indications where targeted therapy can shift the playing field from median survival towards a curative methodology. Just wanted to say a few words to cut through all the hype (both short and long) - step back and understand that sometimes its not about the money but about the promise that this platform can provide to those affected. GL to all

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
ECYT
4.07-0.01(-0.25%)Apr 28 4:00 PMEDT